Universal Health Services, Inc. Announces Financial Results for the Three and Nine-Month Periods Ended September 30, 2026
UHS reported Q3 2026 net revenues of $4.733 billion, up 5.3% YoY, but net income attributable to UHS fell to $308.7 million ($5.22 diluted EPS) from $373.0 million ($5.86) a year earlier. Adjusted EBITDA net of NCI declined to $624.6 million from $670.6 million, with margins compressing to 13.2% from 14.9%; results included a net favorable $21 million pre-tax impact, mostly a $47 million Medicaid supplemental payment benefit offset by a $26 million liability reserve charge tied to a tentative Cumberland litigation settlement.
Key figures
- Eps
- 5.22
- Revenue
- 4733352000
- Revenue Yoy
- 5.3%
- Q3 net income
- 308684000
- Debt to ebitda
- 2.07
- Nine month eps
- 16.86
- Ebitda net of nci
- 640383000
- Nine month revenue
- 13866546000
- Prior year net income
- 372957000
- Shares repurchased 9m
- 3.915 million shares for approximately $689.6 million
- Shares repurchased q3
- 1.35 million shares for approximately $242.1 million
- Nine month revenue yoy
- 7.7%
- Adjusted eps prior year
- 5.69
- Debt to adjusted ebitda
- 2.17
- Liability reserve charge
- $26 million
- Cumberland pre tax charge
- $26 million
- Adjusted ebitda net of nci
- 624645000
- Available revolver capacity
- $1.187 billion
- Remaining repurchase authorization
- $735.4 million
- Net favorable pre tax items q3 2026
- $21 million
- Nine month net cash from operations
- 1481487000
- Medicaid supplemental payment benefit
- $47 million
AI analysis
Red flags5 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.